Loading...
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro
Emicizumab is a humanized bispecific antibody that binds simultaneously to factor (F) IXa and FX replacing the cofactor function of FVIIIa. Because emicizumab recognizes FIX/FIXa and FX/FXa, a question may arise whether emicizumab competes with antithrombin (AT) and/or tissue factor pathway inhibito...
Na minha lista:
| Udgivet i: | TH Open |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Georg Thieme Verlag KG
2018
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524866/ https://ncbi.nlm.nih.gov/pubmed/31249933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1636538 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|